EP Patent

EP3021851A2 — Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant

Assigned to Dr Reddys Laboratories Ltd · Expires 2016-05-25 · 10y expired

What this patent protects

A novel processes for the preparation of suvorexant (formula I), its related compounds and its intermediates that are simple, economical and commercially viable. (I)

USPTO Abstract

A novel processes for the preparation of suvorexant (formula I), its related compounds and its intermediates that are simple, economical and commercially viable. (I)

Drugs covered by this patent

Patent Metadata

Patent number: EP3021851A2
Jurisdiction: EP
Classification: —
Expires: 2016-05-25
Drug substance claim: No
Drug product claim: No
Assignee: Dr Reddys Laboratories Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.